Թϲ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • Թϲ Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Sep 11 2026 UPDATED 9:40 AM

Full Issue

Anthropic Says It Thwarted Use Of Its AI Tools To Devise Biological Weapons

The company said it can't be certain bad actors were using its models for nefarious reasons, but noted 35 “distinct research efforts” with potentially concerning activity, CNN reported. The company, which touts the benefits of AI in scientific research, said newer models have “stronger safeguards that restrict access to a wide range of dual-use biological research queries.”

Anthropic says it has blocked multiple accounts that used the company’s artificial intelligence models in ways that could support the development of biological weapons. In a report published Thursday, the AI company known for its Claude model said it considers biological misuse one of the “most serious risks” to artificial intelligence models. (McPhillips, 9/11)

OpenAI and Anthropic researchers are ramping up calls for an AI slowdown and warning of existential risks to humanity after the resignation of a researcher at Anthropic fueled fresh scrutiny. (Nicol-Schwarz, 9/10)

This week's dire warnings about unchecked artificial intelligence destroying humanity are refocusing attention on how models already are being used in dangerous bioscience experiments — and the lack of safeguards. There's growing alarm about emerging risks from advances like AI-designed viruses. But it's hard to erect guardrails when there's no ironclad way of even knowing how some AI systems will act. (Bettelheim and Owens, 9/11)

On the use of AI in healthcare —

Federal healthcare agencies are accelerating efforts to expand artificial intelligence's role in healthcare, with clinical AI emerging as a top strategic priority for the Centers for Medicare & Medicaid Services. At a healthcare AI event hosted by the Consumer Technology Association (CTA) in Washington, D.C., on Wednesday, Stephanie Carlton, deputy administrator at CMS, outlined the agency's evolving AI strategy as it aims to establish clearer pathways for AI market access and regulation while also exploring reimbursement frameworks for AI-enabled technologies. (Landi, 9/10)

In its current state, industry-driven artificial intelligence (AI) can’t be ethically or responsibly implemented in public health systems, write physicians in the American Journal of Public Health. In the commentary yesterday, Terry Adirim, MD, MPH, of the Uniformed Services University of Health Sciences, and Amy Molten, MD, of Tufts University School of Medicine, said that, without stronger governance, AI poses risks to patients—especially those from historically marginalized groups such as children, racial minorities, indigenous people, older adults, homeless or incarcerated people, undocumented families, rural residents, and people with disabilities. (Van Beusekom, 9/10)

Health systems are increasingly relying on AI tools, including those that are integrated with patients' medical histories. That raises privacy concerns. (Adams, 9/9)

The building that houses the Brigham and Women’s Hospital emergency department opened in 2022. But by 2025, it was already too small. One early September evening, the emergency room had 59 patients — 152, if you counted everyone in the waiting room. (Trang, 9/9)

Medtronic is exploring new ways to use artificial intelligence, robotics and other emerging technologies to transform how care is delivered, the company’s chief technology officer said. The company, one of the world’s largest medical technology firms, has emerged as a new competitor in soft-tissue surgical robotics after the Food and Drug Administration authorized its Hugo robotic-assisted surgery system in December for urologic surgical procedures. (Dubinsky, 9/10)

Also —

A group representing more than 800 former employees of the Environmental Protection Agency on Thursday sounded the alarm over the health consequences of data centers. It warned that Trump administration policies to weaken pollution safeguards and speed up approvals of the facilities threatened to exacerbate those health harms. (Tabuchi, 9/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, September 11
  • Thursday, September 10
  • Wednesday, September 9
  • Tuesday, September 8
  • Friday, August 28
  • Thursday, August 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • Թϲ
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF